ADVERTISEMENT

ICICI Securities: India Pharma Market Resilient And Growth Pick-Up To Sustain Premium Valuations

ICICI Securities: India Pharma Market Resilient And Growth Pick-Up To Sustain Premium Valuations

Bottles of Duloxetine delayed-release capsules await labeling on the production line inside the packaging unit at the Lupin Ltd. pharmaceutical plant in  Goa, India (Photographer Dhiraj Singh/Bloomberg)
Bottles of Duloxetine delayed-release capsules await labeling on the production line inside the packaging unit at the Lupin Ltd. pharmaceutical plant in Goa, India (Photographer Dhiraj Singh/Bloomberg)
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More